On Sunday, Waltham-based NeuroMetrix will unveil the new consumer model of its wearable pain-relief device as the company looks forward to launching sales in coming months.
The device, called Quell, is largely the same as the company’s Sensus device, which was first approved by the U.S. Food and Drug Administration in 2012 for use by patients with chronic pain due to diabetes, sciatica, fibromyalgia, and degenerative knee conditions. That device, which uses electrical stimulation to raise levels of a a natural painkiller called enkephalins, received additional approval the following year for use while sleeping, and last July, was given the OK to be sold over-the-counter.
Help employers find you! Check out all the jobs and post your resume.
